ACAnnibale Cois

Annibale Cois

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Annibale Cois has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Excess Heat and Excess Deaths: Application of Heat-Health Metrics to Assess Mortality Risk in the Limpopo Province of South Africa

    by Neville A. Sweijd, Albertus J. Smit, Annibale Cois, Tom A. Moultrie, Sarah J. Roffe, Johan Malherbe, Pamela Groenewald

    Extreme heat and humidity are increasing globally, with direct implications for heat-related mortality. This study examined associations between daily natural-death counts and heat exposure in the five district municipalities of Limpopo Province, South Africa, where isolated surges in excess deaths were detected by mortality surveillance in November 2023 and December 2024. We combined spatially averaged district-level meteorological observations from 1 January 1991 to 20 July 2025 with daily mortality data from 1 January 2022 to 10 May 2025 and analysed the Excess Heat Factor (EHF) and apparent temperature (AT) in calendar-matched case-crossover models of observed death counts for all ages and ages 60 yrs and older. EHF entered the models as its positive part in local severity units. The analysis showed that absolute humidity, maximum temperature, minimum temperature and diurnal temperature range increased across districts, with the fastest proportional increases in the extreme exposure categories. At provincial level, for all ages, each severity unit of lag 0–1 EHF was associated with a mortality rate ratio of 1.191 (95% confidence interval, CI: 1.168–1.214) and extreme heatwave days carried rate ratios of 1.830 (95% CI: 1.652–2.027). Each interquartile-range increase in AT was associated with rate ratios of 1.074 (95% CI: 1.061–1.088). The EHF–mortality association was present in every district and heterogeneous in magnitude ranging from 1.092 (1.036–1.151) to 1.231 (1.169–1.296) across the districts, whereas the AT association was small and spatially uniform once EHF was included in the model. For both EHF and AT (and combined), the association with mortality was ubiquitously amplified in all models, in all districts for the 60-yrs-and-older age class. A proposed EHF-based warning was tested retrospectively and showed that both mortality surges were preceded by “warning-level” EHF alerts in every district. A district-specific, severity-based EHF alert scheme, evaluated here against the 2022–2025 mortality series, could improve municipal heat-health warning systems in Limpopo and provides a template for similar analyses elsewhere in South Africa.

  • Open Access

    Trends in general and abdominal obesity in South African adults, 1998 - 2017: A joint analysis of nine population surveys

    by A Cois, J H Goedecke, K Adjaye-Gbewonyo

    Background. Obesity, a health condition characterised by abnormal accumulation of body fat, is a major public health problem, with the number of affected individuals forecasted to rise sharply worldwide. Local epidemiological data are needed to understand the epidemic’s specific characteristics and to implement effective evidence-based prevention strategies. Objective. To provide insight into the South African (SA) obesity epidemic by analysing trends in the prevalence of general and abdominal obesity between 1998 and 2017. Methods. Harmonised data on 134 029 adults (aged ≥18 years) from nine population surveys were analysed. For each survey dataset, the population distribution of body mass index (BMI), waist circumference (WC) and waist-to-height ratio (WHtR) was estimated, along with the prevalence of obesity and abdominal obesity according to standard epidemiological definitions. Metaregression models were fitted to estimate and compare the average rates of change of the multiple obesity indicators during the study period, for the whole population and by sex, population group, province of residence and geographical type (urban v. rural). Results. Among women, the distribution of BMI, WC and WHtR showed a significant rightward shift between 1998 and 2017, with increases in median values of 1.38 (95% confidence interval (CI) 0.91 - 1.84) kg/m2/decade for BMI, 4.04 (1.27 - 6.82) cm/decade for WC and 0.03 (0.01 - 0.04) units/decade for WHtR. The prevalence of obesity rose sharply, from 29.5% (28.1 - 30.8%) in 1998 to 42.7% (41.0 - 44.4%) in 2017. The prevalence of WC-defined and WHtR-defined abdominal obesity increased from 60.0% (58.6 - 61.3%) to 77.2% (76.0 - 78.4%), and from 62.8% (61.4 - 64.2%) to 78.7% (77.4 - 80.0%), respectively. Among men, changes in the distribution were modest and median trends not statistically significant, at 0.1 (–0.27 - 0.47) kg/m2/decade for BMI, 1.19 (–0.48 - 2.87) cm/decade for WC and 0.01 (–0.01 - 0.02) units/decade for WHtR. Obesity prevalence rose from 10.1% (8.9 - 11.3%) in 1998 to 12.1% (10.7 - 13.4%) in 2017, WC-defined abdominal obesity from 21.6% (19.8 - 23.4%) to 26.4% (24.3 - 28.4%) and WHtR-defined abdominal obesity from 39.7% (37.8 - 41.7%) to 42.8% (40.6% - 45.0%). The prevalence of both general and abdominal obesity also differed across geographical type, province and population group, with a disproportionately rapid increase among groups and areas that initially exhibited lower prevalence. Conclusion. Between 1998 and 2017, the prevalence of both general and abdominal obesity in the SA adult population rose substantially. Evidence-based prevention efforts and policy strategies are urgently needed to curb the growing burden, especially among women.


  • Open Access

    Exploring Factors Affecting Participation in Oncology Clinical Trials in Saudi Arabia: Insights Into Willingness and Barriers

    by Mohammad Alkaiyat, Kanan Alshammari, Annibale Cois

    PURPOSE: To assess willingness of patients with cancer to participate in observational studies (OBS) and clinical trials (CT) and to examine the factors influencing their decision to join CT. METHODS: A cross-sectional study using a systematic sampling strategy was conducted from December 2023 to June 2024. Data were collected directly from patients and their medical charts. Logistic regression was performed to identify significant predictors of patients' willingness to participate in CT. RESULTS: A total of 367 patients participated, 58.9% were females, and 59.8% had stage IV disease. Most participants (81%) had a performance status (PS) of 0-1, with only 1.9% having prior experience with a CT and 9% with OBS. Willingness to join OBS was higher than willingness to join CT (64% v 31.6%, P < .001). Key barriers included fear of side effects (61.6%), lack of information (46.3%), and concerns about the investigational product (41.6%). Motivators were having their treating physician as the principal investigator (42.5%) and prior human testing of the product (40.6%). Patients who underwent surgery or believed that their physical or psychological condition is unsuitable for trials were less likely to participate ( P < .05, odds ratio [OR], 0.30, 0.38, 0.37, respectively). Patients with a friend or relative who had joined a trial were more willing to participate ( P < .05, OR, 3.48). CONCLUSION: The results highlight a low level of willingness to participate in CT. Some barriers could be avoided during the study design phase. Discrepancies between patients' self-assessed PS and physicians' evaluations may lower the enrollment rates. Encouraging patients who have participated in CTs to share their experiences with the family and friends could significantly improve the community's willingness to join CT.

  • Open Access

    Application and implications of new global definitions of obesity: a cross-sectional study of South African women

    by Jasantha Odayar, Mustafa Shuaib, Jennifer Jao, Annibale Cois, Julia H Goedecke, Jami L Josefson, Elton Mukonda, Elaine J Abrams, Landon Myer

  • Open Access

    Epidemiology of adult obesity

    by J H Goedecke, J Hellig, M Conradie-Smit, W May, A Cois

    RECOMMENDATIONS 1. Healthcare providers should recognise and treat obesity as a chronic disease, caused by abnormal or excess body fat accumulation (adiposity) that impairs health, with increased risk of premature morbidity and mortality (Level 2b, Grade B). 2. The development of evidence-informed strategies at the health system and policy level should be directed at managing obesity in adults (Level 2b, Grade B). 3. Continued longitudinal national and regional surveillance of obesity that includes self-reported and measured data (i.e. heights, weights, waist circumferences) should be conducted on a regular basis (Level 2b, Grade B).


  • Open Access

    Estimating Trends in Cardiovascular Disease Risk for the EXPOSE (Explaining Population Trends in Cardiovascular Risk: A Comparative Analysis of Health Transitions in South Africa and England) Study: Repeated Cross-Sectional Study

    by Shaun Scholes, Jennifer S Mindell, Mari Toomse-Smith, Annibale Cois, Kafui Adjaye-Gbewonyo

    Background: Cardiovascular diseases (CVDs) are the leading cause of death globally. Demographic, behavioral, socioeconomic, health care, and psychosocial variables considered risk factors for CVD are routinely measured in population health surveys, providing opportunities to examine health transitions. Studying the drivers of health transitions in countries where multiple burdens of disease persist (eg, South Africa), compared with countries regarded as models of “epidemiologic transition” (eg, England), can provide knowledge on where best to intervene and direct resources to reduce the disease burden. Objective: The EXPOSE (Explaining Population Trends in Cardiovascular Risk: A Comparative Analysis of Health Transitions in South Africa and England) study analyzes microlevel data collected from multiple nationally representative population health surveys conducted in these 2 countries between 1998 and 2017. Creating a harmonized dataset by pooling repeated cross-sectional surveys to model trends in CVD risk is challenging due to changes in aspects such as survey content, question wording, inclusion of boost samples, weighting, measuring equipment, and guidelines for data protection. This study aimed to create a harmonized dataset based on the annual Health Surveys for England to estimate trends in mean predicted 10-year CVD risk (primary outcome) and its individual risk components (secondary outcome). Methods: We compiled a harmonized dataset to estimate trends between 1998 and 2017 in the English adult population, including the primary and secondary outcomes, and potential drivers of those trends. Laboratory- and non–laboratory-based World Health Organization (WHO) and Globorisk algorithms were used to calculate the predicted 10-year total (fatal and nonfatal) CVD risk. Sex-specific estimates of the mean 10-year CVD risk and its components by survey year were calculated, accounting for the complex survey design. Results: Laboratory- and non–laboratory-based 10-year CVD risk scores were calculated for 33,628 and 61,629 participants aged 40 to 74 years, respectively. The absolute predicted 10-year risk of CVD declined significantly on average over the last 2 decades in both sexes (for linear trend; all P<.001). In men, the mean of the laboratory-based WHO risk score was 10.1% (SE 0.2%) and 8.4% (SE 0.2%) in 1998 and 2017, respectively; corresponding figures in women were 5.6% (SE 0.1%) and 4.5% (SE 0.1%). In men, the mean of the non–laboratory-based WHO risk score was 9.6% (SE 0.1%) and 8.9% (SE 0.2%) in 1998 and 2017, respectively; corresponding figures in women were 5.8% (SE 0.1%) and 4.8% (SE 0.1%). Predicted CVD risk using the Globorisk algorithms was lower on average in absolute terms, but the pattern of change was very similar. Trends in the individual risk components showed a complex pattern. Conclusions: Harmonized data from repeated cross-sectional health surveys can be used to quantify the drivers of recent changes in CVD risk at the population level.


  • Open Access

    SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities

    by Hannah Hussey, Helena Vreede, Mary-Ann Davies, Alexa Heekes, Emma Kalk, Diana Hardie, Gert van Zyl, Michelle Naidoo, Erna Morden, Jamy-Lee Bam, et al.

    In low- and middle-income countries where SARS-CoV-2 testing is limited, seroprevalence studies can help describe and characterise the extent of the pandemic, as well as elucidate protection conferred by prior exposure. We conducted repeated cross-sectional serosurveys (July 2020 –November 2021) using residual samples from patients from Cape Town, South Africa, sent for routine laboratory studies for non-COVID-19 conditions. SARS-CoV-2 anti-nucleocapsid antibodies and linked clinical information were used to investigate: (1) seroprevalence over time and risk factors associated with seropositivity, (2) ecological comparison of seroprevalence between subdistricts, (3) case ascertainment rates, and (4) the relative protection against COVID-19 associated with seropositivity and vaccination statuses. Among the subset sampled, seroprevalence of SARS-CoV-2 in Cape Town increased from 39.19% (95% confidence interval [CI] 37.23–41.19) in July 2020 to 67.8% (95%CI 66.31–69.25) in November 2021. Poorer communities had both higher seroprevalence and COVID-19 mortality. Only 10% of seropositive individuals had a recorded positive SARS-CoV-2 test. Using COVID-19 hospital admission and death data at the Provincial Health Data Centre, antibody positivity before the start of the Omicron BA.1 wave (28 November 2021) was strongly protective for severe disease (adjusted odds ratio [aOR] 0.15; 95%CI 0.05–0.46), with additional benefit in those who were also vaccinated (aOR 0.07, 95%CI 0.01–0.35). The high population seroprevalence in Cape Town was attained at the cost of substantial COVID-19 mortality. At the individual level, seropositivity was highly protective against subsequent infections and severe COVID-19 disease. In low-income communities, where diagnostic testing capacity is often limited, surveillance systems dependent on them will underestimate the true extent of an outbreak. Rapidly conducted seroprevalence studies can play an important role in addressing this.


  • Open Access

    Estimating Trends in Cardiovascular Disease Risk for the EXPOSE (Explaining Population Trends in Cardiovascular Risk: A Comparative Analysis of Health Transitions in South Africa and England) Study: Repeated Cross-Sectional Study (Preprint)

    by Shaun Scholes, Jennifer S Mindell, Mari Toomse-Smith, Annibale Cois, Kafui Adjaye-Gbewonyo

    BACKGROUND Cardiovascular diseases (CVDs) are the leading cause of death globally. Demographic, behavioral, socioeconomic, health care, and psychosocial variables considered risk factors for CVD are routinely measured in population health surveys, providing opportunities to examine health transitions. Studying the drivers of health transitions in countries where multiple burdens of disease persist (eg, South Africa), compared with countries regarded as models of “epidemiologic transition” (eg, England), can provide knowledge on where best to intervene and direct resources to reduce the disease burden. OBJECTIVE The EXPOSE (Explaining Population Trends in Cardiovascular Risk: A Comparative Analysis of Health Transitions in South Africa and England) study analyzes microlevel data collected from multiple nationally representative population health surveys conducted in these 2 countries between 1998 and 2017. Creating a harmonized dataset by pooling repeated cross-sectional surveys to model trends in CVD risk is challenging due to changes in aspects such as survey content, question wording, inclusion of boost samples, weighting, measuring equipment, and guidelines for data protection. This study aimed to create a harmonized dataset based on the annual Health Surveys for England to estimate trends in mean predicted 10-year CVD risk (primary outcome) and its individual risk components (secondary outcome). METHODS We compiled a harmonized dataset to estimate trends between 1998 and 2017 in the English adult population, including the primary and secondary outcomes, and potential drivers of those trends. Laboratory- and non–laboratory-based World Health Organization (WHO) and Globorisk algorithms were used to calculate the predicted 10-year total (fatal and nonfatal) CVD risk. Sex-specific estimates of the mean 10-year CVD risk and its components by survey year were calculated, accounting for the complex survey design. RESULTS Laboratory- and non–laboratory-based 10-year CVD risk scores were calculated for 33,628 and 61,629 participants aged 40 to 74 years, respectively. The absolute predicted 10-year risk of CVD declined significantly on average over the last 2 decades in both sexes (for linear trend; all P<.001). In men, the mean of the laboratory-based WHO risk score was 10.1% (SE 0.2%) and 8.4% (SE 0.2%) in 1998 and 2017, respectively; corresponding figures in women were 5.6% (SE 0.1%) and 4.5% (SE 0.1%). In men, the mean of the non–laboratory-based WHO risk score was 9.6% (SE 0.1%) and 8.9% (SE 0.2%) in 1998 and 2017, respectively; corresponding figures in women were 5.8% (SE 0.1%) and 4.8% (SE 0.1%). Predicted CVD risk using the Globorisk algorithms was lower on average in absolute terms, but the pattern of change was very similar. Trends in the individual risk components showed a complex pattern. CONCLUSIONS Harmonized data from repeated cross-sectional health surveys can be used to quantify the drivers of recent changes in CVD risk at the population level.

  • Open Access

    Estimating the changing burden of disease attributable to low levels of physical activity in South Africa for 2000, 2006 and 2012

    by I Neethling, E V Lambert, A Cois, R A Roomaney, O F Awotiwon, R Pacella, D Bradshaw, V Pillay-Van Wyk

    Background. Physical activity is associated with a lower risk of cardiovascular outcomes, certain cancers and diabetes. The previous South African Comparative Risk Assessment (SACRA1) study assessed the attributable burden of low physical activity for 2000, but updated estimates are required, as well as an assessment of trends over time.Objective. To estimate the national prevalence of physical activity by age, year and sex and to quantify the burden of disease attributable to low physical activity in South Africa (SA) for 2000, 2006 and 2012.Methods. Comparative risk assessment methodology was used. Physical activity was treated as a categorical variable with four categories, i.e. inactive, active, very active and highly active. Prevalence estimates of physical activity levels, representing the three different years, were derived from two national surveys. Physical activity estimates together with the relative risks from the Global Burden of Disease, Injuries, and Risk Factors (GBD) 2016 study were used to calculate population attributable fractions due to inactive, active and very active levels of physical activity relative to highly active levels considered to be the theoretical minimum risk exposure (>8 000 metabolic equivalent of time (MET)-min/wk), in accordance with the GBD 2016 study. These were applied to relevant disease outcomes sourced from the Second National Burden of Disease Study to calculate attributable deaths, years of life lost, years lived with disability and disability adjusted life years (DALYs). Uncertainty analysis was performed using Monte Carlo simulation.Results. The prevalence of physical inactivity (<600 METS) decreased by 16% and 8% between 2000 and 2012 for females and males, respectively. Attributable DALYs due to low physical activity increased between 2000 (n=194 284) and 2006 (n=238 475), but decreased thereafter in 2012 (n=219 851). The attributable death age-standardised rates (ASRs) declined between 2000 and 2012 from 60/100 000 population in 2000 to 54/100 000 population in 2012. Diabetes mellitus type 2 displaced ischaemic heart disease as the largest contributor to attributable deaths, increasing from 31% in 2000 to 42% in 2012.Conclusions. Low physical activity is responsible for a large portion of disease burden in SA. While the decreased attributable death ASR due to low physical activity is encouraging, this burden may be lowered further with an additional reduction in the overall prevalence of physical inactivity, in particular. It is concerning that the attributable burden for diabetes mellitus is growing, which suggests that existing non-communicable disease policies need better implementation, with ongoing surveillance of physical activity, and population- and community-based interventions are required in order to reach set targets.